Aim: Human papillomavirus (HPV) has been reported to be associated with oral and oropharyngeal cancer. However, little information is available about the epidemiology of oral HPV infection in Jamaica. The purpose of the present study was to assess the prevalence of oral HPV strains using the oral rinse method in HIV and non-HIV Jamaican patients, as well as to determine the association of HPV with sexual practices, smoking, and alcohol use.
| INTRODUC TI ON
Oral squamous cell carcinoma (OSCC) is the fifth most common cancer and constitutes up to 90% of head and neck malignancies. 1, 2 Oral and pharyngeal cancer is a significant global public health issue, with an estimated 49 670 adults (35 720 men and 13 950 women) in the USA in 2017 diagnosed with this type of cancer. 3, 4 Oral human papillomavirus (OHPV) is the cause of a subset of oropharyngeal squamous cell carcinomas. [5] [6] [7] In general, genital HPV
| Study population
Dental patients with no HIV infections at the UMDP and HIVinfected patients at CHARES >18 years were eligible to participate in the study. The status of HIV infection in the UMDP participants was self-reported. Participants signed written consent forms for participation and were not compensated for their role in the study.
Patients who were observed with emergency dental conditions (ie inability to open their mouth due to infections, such as Ludwig's angina or space infection) and who did not consent were excluded.
| Data collection

| Questionnaire and oral examination
Each study participant completed a questionnaire that was administered privately by trained personnel. The questionnaire focused on demographic and behavioral data that included age, sex, occupation, education, income, smoking history, alcohol habits, marital status, lifetime sexual partners, children, and cervical Pap smear test. All study participants underwent an oral examination in which the status of their oral mucosa, teeth, gingiva, and oropharynx was examined by an oral and maxillofacial pathologist.
The oral examination findings were recorded on a clinical datacollection form.
| Sample collection
Following the oral examination, an oral rinse sample was collected from each participant by swishing and gargling 10 mL sterile saline for 15-20 seconds and then emptying into a 50-mL biologic specimen collection cup (US patent: 5672321). Each study sample was labeled with an anonymous study reference number and stored at -70°C within 30 minutes of collection and until subsequent DNA extraction. The samples were processed in random order at the
Department of Microbiology of the Faculty of Medical Sciences,
Mona Campus, The University of the West Indies, Jamaica.
| Molecular methods for human papillomavirus genotyping
| DNA extraction
Following sample collection, the salivary samples were prepared for HPV genotyping. The linear array (LA) HPV genotyping test (Roche Diagnostics, Mannheim, Germany) is based on four major processes: specimen preparation, polymerase chain reaction (PCR) amplification of target DNA using HPV primers, hybridization of the amplified products to oligonucleotide probes, and detection of the probe-bound amplified products by colorimetric determination. The specimen preparation was done using the AmpliLute liquid media extraction kit (Roche Diagnostics, Germany) for HPV target DNA and human genomic DNA suitable for PCR amplification. Fifty microliters of the extracted DNA was amplified. Lysis was performed by a 1 hour external lysis at 65°C with proteinase K, chaotropic agent, and detergent. This was followed by isolation and purification of DNA over a column and elution with elution reagent. The β-globin gene was isolated concurrently and cellular adequacy, extraction, and amplification for each individually-processed specimen was assessed. of each DNA extract was amplified in the 100 μL PCR; otherwise, the protocol from the manufacturer was followed. Capture probe sequences were located in the polymorphic regions of L1 bound by these primers. An additional primer pair targeted the human β-globin gene to provide a control for cell adequacy, extraction, and sample amplification. Samples negative for both β-globin and HPV were considered inadequate for interpretation and were omitted from further analysis.
| Statistical analysis
Patient characteristics were described using median and inter- 
| RE SULTS
In total, 174 eligible participants were recruited for the present study. Genetic testing for oral HPV was completed for 104 (59.8%) Tables 1-3 .
A slightly larger proportion of females was recruited in the present study when compared to males (52.9% vs 47.1%, respectively.) Table 1) .
Approximately 56% of the participants who were positive for oral HPV only completed secondary school education. Participants with a secondary school education represented the largest proportion of oral HPV-positive participants, followed by primary school (33%) and graduate college (11%) ( Table 1) .
Four (44%) of the participants who were positive for oral HPV were employed as service workers. Participants who were service workers represented the largest proportion of oral HPV-positive participants, followed by workers not classified by International
Labour Organisation occupation (33%) and students (11%) ( Table 1) .
Participants with no income represented the largest proportion of oral HPV-positive participants (67%), followed by those who had three-to-five lifetime sexual partners (22%) and those who had oneto-two lifetime sexual partners (11%) ( Table 1) .
Five (56%) of the participants who were positive for oral smoker positive for oral HPV had been smoking for 6-9 years. Six of the participants who were positive for oral HPV (67%) consumed alcohol (Table 2) .
Oral HPV status disaggregated by parity and female sex showed that two (40%) of the female participants positive for oral HPV had one complete pregnancy, two (40%) reported three or more complete pregnancies, and one (20%) reported having none. Table 3) .
None of the participants who were positive for oral HPV (100%)
had oral manifestation at the time of recruitment, and there was no relationship between oral HPV status and oral manifestations (Fisher's exact test, P>.05) ( Table 3) .
Fifty-six percent (56%) of the participants who were positive for oral HPV were identified as having HPV-84 type. The most common HPV type identified was HPV-84, followed by HPV-72 (22%), HPV-
(11%), and HPV-1S39 (11%). Only one participant had more than
one HPV type present. The findings for the variables investigated in the HPV-positive participants are summarized in Table 4 . 
| D ISCUSS I ON
The purpose of the present study was to determine HPV prevalence and type using the oral rinse method from HIV and non-HIV Jamaican patients. HPV DNA was detected in a low number of the study population (8.65%); 55.6% of the HPV-positive participants were female and 44.4% were male. HPV-84 was the most prevalent subtype identified in the present study. We did not observe any participants with high-risk HPV types in the present study. The prevalence rate found in the present study was similar to reports from other countries. A study in the USA reported the prevalence of oral HPV to be 6.9%, 23 whereas another study reported the prevalence of oral HPV in HIV patients in the USA at 39%. 8 Epidemiological studies across the globe have reported varying prevalence rates of oral HPV, such as 10.4% for Denmark, 24 9.3% for Sweden, 25 5% for Scotland, 26 and 5.6% for South Africa
17
( Table 5 ).
In the present study, HPV genotypes 62, 72, and 84 were detected among the population screened (Table 6 ). HPV-84 was found to be the most common genotype detected in both HIV and non-HIV patients. The prevalence of HPV-84 among HIV patients was consistent with a study from the USA. Denmark, 24 Sweden, 25 and Scotland, 26 whereas a South African study reported HPV-72 as the most common type. 17 The low proportion of high-risk HPV types found among the Jamaican sample population might suggest a lower risk of developing HPV-related oral cancer. However, a nationwide study is required to confirm the status of oral HPV infection in Jamaica.
The various risk factors for oral and oropharyngeal HPV infec- Although tobacco and alcohol are strong causative factors for head and neck cancers, they are not considered strong risk factors for HPV-associated oropharyngeal cancers. 23 In the present study, There was a slightly higher prevalence of HPV-positive among participants who were single, followed by separated, divorced, or widowed. However, this association was not statistically significant.
No statistical relationship was found between income status and HPV-positive status.
The present study did not show adequate statistical relationships with the parameters studied, and the reasons for this are not clear, but possible explanations are due to the study's limitations. In the present study, important future research directions and public health implications were provided. Our study hypothesis can assist with the development of public health interventions, such as a HPV vaccination typing, which once identified, can be used in national vaccination programs.
| Study limitations and strengths
One of the strengths of the present study was that it is the first study of this nature to investigate oral HPV prevalence in Jamaica.
A limitation of the study was the low number of study participants, which was restricted due to a lack of funding. Another limitation was the fact that not all the participants opted to test for HIV, which might also have an influence on the conclusions. The results might be biased by the fact that participants were attending health clinics, and thus demonstrating health-seeking behavior that might not be truly representative of the wider population in Jamaica.
| CON CLUS ION
To the best of our knowledge, the present study is the first on oral HPV prevalence among the Jamaican population. We employed a validated and well-known method of specimen collection from the oral cavity and HPV molecular testing in the present study, and reported a low prevalence of HPV genotypes in oral rinses in both HIV and non-HIV Jamaican patients.
Our future research will be to investigate and understand HPV types nationwide, and influence policy-making in regard to HPV vaccinations. TA B L E 6 Prevalence of HPV types in the present study 
